Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05227781 · ClinicalTrials.gov registry record · NA
8 Weeks of L-CIT Supplementation and LIRET on Vascular Function in Hypertensive Postmenopausal Women
A NA study, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT05227781 is a NA study that has completed, run by Texas Tech University. The registered enrollment target is 29 participants.
The verdict
NCT05227781, a NA study, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The overall objective of this project is to bring forth evidence that L-Citrulline (L-CIT) supplementation and low intensity resistance exercise training (LIRET) alone and combined will improve vascular function and muscle fitness (mass, strength, and exercise performance) in postmenopausal women with hypertension. The investigators' central hypothesis is that adjuvant L-CIT supplementation may synergistically enhance vascular (arterial stiffness, BP, muscle oxygenation, blood flow) and muscular (strength, exercise performance) responses to LIRET in postmenopausal women with hypertension by improving endothelial vasodilatory function.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT L-Citrulline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-05-24 |
| Est. Completion | 2022-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05227781
The ClinicalTrials.gov registry entry for NCT05227781 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05227781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05227781 about?
NCT05227781 is a clinical study titled "8 Weeks of L-CIT Supplementation and LIRET on Vascular Function in Hypertensive Postmenopausal Women". The overall objective of this project is to bring forth evidence that L-Citrulline (L-CIT) supplementation and low intensity resistance exercise training (LIRET) alone and combined will improve vascular function and muscle fitness (mass, strength, and exercise performance) in postmenopausal women wi...
What is the current status of trial NCT05227781?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-05-24. Estimated completion is 2022-01-10.
What interventions are being tested in trial NCT05227781?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), L-Citrulline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05227781?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.